Arovella Therapeutics trading halt request details

Arovella Therapeutics Limited (ASX: $ALA) has requested a trading halt from the Australian Securities Exchange (ASX) for its ordinary shares from 22 March 2024 until the commencement of trading on 26 March 2024. The trading halt is pending the release of an announcement regarding a capital raise and subsequent issue of securities. The company is not aware of any reason why the trading halt should not be granted.

Executive commentary on trading halt request

The Company requests a trading halt immediately, pending the release of an announcement regarding a capital raise and subsequent issue of securities. The trading halt is expected to remain in place until the earlier of the commencement of trade on 26 March 2024 or the release of an announcement by the Company in respect of the capital raise. This request has been authorised by the Board of Arovella Therapeutics Limited.

Summary of Arovella Therapeutics trading halt request

Arovella Therapeutics Limited (ASX: $ALA) has requested a trading halt from the ASX in anticipation of an upcoming announcement related to a capital raise and subsequent issue of securities. The halt is expected to be in place until the earlier of the commencement of trade on 26 March 2024 or the release of the announcement by the Company. The request has been authorised by the Board of Arovella Therapeutics Limited. The company aims to provide the market with necessary information about the trading halt and the upcoming announcement.